Optimal duration of dual antiplatelet therapy after percutaneous coronary intervention with drug eluting stents: meta-analysis of randomised controlled trials
EP Navarese, F Andreotti, V Schulze, M Kołodziejczak… - bmj, 2015 - bmj.com
Objective To assess the benefits and risks of short term (< 12 months) or extended (> 12
months) dual antiplatelet therapy (DAPT) versus standard 12 month therapy, following …
months) dual antiplatelet therapy (DAPT) versus standard 12 month therapy, following …
Duration of dual antiplatelet therapy after percutaneous coronary intervention with drug-eluting stent: systematic review and network meta-analysis
Objective To evaluate the efficacy and safety of standard term (12 months) or long term (> 12
months) dual antiplatelet therapy (DAPT) versus short term (< 6 months) DAPT after …
months) dual antiplatelet therapy (DAPT) versus short term (< 6 months) DAPT after …
Clinical impact of extended dual antiplatelet therapy after percutaneous coronary interventions in the drug-eluting stent era: a meta-analysis of randomized trials
Aims The aim of this study was to evaluate benefits and risks of extending dual antiplatelet
therapy (DAPT) after percutaneous coronary intervention (PCI) in the drug-eluting stent era …
therapy (DAPT) after percutaneous coronary intervention (PCI) in the drug-eluting stent era …
Dual antiplatelet therapy after percutaneous coronary intervention and drug-eluting stents: a systematic review and network meta-analysis
Background: The optimal duration of dual antiplatelet therapy (DAPT) after percutaneous
coronary intervention with drug-eluting stents remains uncertain. We compared short-term (< …
coronary intervention with drug-eluting stents remains uncertain. We compared short-term (< …
Mortality in patients treated with extended duration dual antiplatelet therapy after drug-eluting stent implantation: a pairwise and Bayesian network meta-analysis of …
T Palmerini, U Benedetto, L Bacchi-Reggiani… - The Lancet, 2015 - thelancet.com
Background Despite recent studies, the optimum duration of dual antiplatelet therapy
(DAPT) after coronary drug-eluting stent placement remains uncertain. We performed a meta …
(DAPT) after coronary drug-eluting stent placement remains uncertain. We performed a meta …
Meta-analysis of randomized clinical trials comparing short-term versus long-term dual antiplatelet therapy following drug-eluting stents
G El-Hayek, F Messerli, S Bangalore, MK Hong… - The American journal of …, 2014 - Elsevier
Current guidelines recommend 12 months of dual antiplatelet therapy (DAPT) after drug-
eluting stent (DES) implantation in the absence of increased bleeding risk. Studies have …
eluting stent (DES) implantation in the absence of increased bleeding risk. Studies have …
Very short vs. long dual antiplatelet therapy after second generation drug-eluting stents in 35 785 patients undergoing percutaneous coronary interventions: a meta …
S Benenati, M Galli, V De Marzo… - European Heart …, 2021 - academic.oup.com
Aim To provide an updated assessment of the efficacy–safety profile of very short (1 or 3
months) dual antiplatelet therapy (DAPT) compared with long (12 months) DAPT in patients …
months) dual antiplatelet therapy (DAPT) compared with long (12 months) DAPT in patients …
Short dual antiplatelet therapy followed by P2Y12 inhibitor monotherapy vs. prolonged dual antiplatelet therapy after percutaneous coronary intervention with second …
D Giacoppo, Y Matsuda, LN Fovino… - European heart …, 2021 - academic.oup.com
Aims After percutaneous coronary intervention (PCI) with second-generation drug-eluting
stent (DES), whether short dual antiplatelet therapy (DAPT) followed by single antiplatelet …
stent (DES), whether short dual antiplatelet therapy (DAPT) followed by single antiplatelet …
Duration of dual antiplatelet therapy after drug-eluting stent implantation: a systematic review and meta-analysis of randomized controlled trials
Background: The optimal duration of dual antiplatelet therapy (DAPT) after drug-eluting stent
(DES) implantation is unclear, and its risks and benefits may vary according to DES …
(DES) implantation is unclear, and its risks and benefits may vary according to DES …
Bleeding-related deaths in relation to the duration of dual-antiplatelet therapy after coronary stenting
T Palmerini, L Bacchi Reggiani, D Della Riva… - Journal of the American …, 2017 - jacc.org
Background: Although some randomized controlled trials (RCTs) and meta-analyses have
suggested that prolonged dual-antiplatelet therapy (DAPT) may be associated with …
suggested that prolonged dual-antiplatelet therapy (DAPT) may be associated with …
相关搜索
- antiplatelet therapy meta analysis
- antiplatelet therapy stent implantation
- meta analysis stent implantation
- antiplatelet therapy drug eluting
- meta analysis drug eluting
- antiplatelet therapy optimal duration
- antiplatelet therapy mortality in patients
- meta analysis mortality in patients
- meta analysis optimal duration
- meta analysis short term
- host idea coronary intervention
- ultrathin struts coronary intervention
- clinical impact stent era
- meta analysis clinical impact
- meta analysis stent era